Ethyl 1-[3-(2-morpholin-4-yl-2-oxoethyl)phenyl]-5,5-dioxo-4H-thiochromeno[3,4-d]pyrazole-3-carboxylate
C25H25N3O6S — CID 153022947
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 1-[3-(2-morpholin-4-yl-2-oxoethyl)phenyl]-5,5-dioxo-4H-thiochromeno[3,4-d]pyrazole-3-carboxylate
Ethyl 1-[3-(2-morpholin-4-yl-2-oxoethyl)phenyl]-5,5-dioxo-4H-thiochromeno[3,4-d]pyrazole-3-carboxylate (PubChem CID 153022947) has the molecular formula C25H25N3O6S and a molecular weight of 495.56 g/mol. Its IUPAC name is ethyl 1-[3-(2-morpholin-4-yl-2-oxoethyl)phenyl]-5,5-dioxo-4H-thiochromeno[3,4-d]pyrazole-3-carboxylate.
Molecular Properties
| Compound Name | Ethyl 1-[3-(2-morpholin-4-yl-2-oxoethyl)phenyl]-5,5-dioxo-4H-thiochromeno[3,4-d]pyrazole-3-carboxylate |
|---|---|
| PubChem CID | 153022947 |
| Molecular Formula | C25H25N3O6S |
| Molecular Weight | 495.56 g/mol |
| Exact Mass | 495.15 |
| IUPAC Name | ethyl 1-[3-(2-morpholin-4-yl-2-oxoethyl)phenyl]-5,5-dioxo-4H-thiochromeno[3,4-d]pyrazole-3-carboxylate |
| SMILES | CCOC(=O)c1nn(-c2cccc(CC(=O)N3CCOCC3)c2)c2c1CS(=O)(=O)c1ccccc1-2 |
| InChI | InChI=1S/C25H25N3O6S/c1-2-34-25(30)23-20-16-35(31,32)21-9-4-3-8-19(21)24(20)28(26-23)18-7-5-6-17(14-18)15-22(29)27-10-12-33-13-11-27/h3-9,14H,2,10-13,15-16H2,1H3 |
| InChIKey | VCHCBRURTRYOTK-UHFFFAOYSA-N |
| XLogP | 2.40 |
| TPSA | 107.80 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 495.56 |
| LogP ≤ 5 | 2.40 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153022947 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.